Ozempic Is Just the Beginning: What’s Next in Weight Loss Drugs | Dr Spencer Nadolsky

💬 Dr Spencer Nadolsky is an obesity and lipid specialist, and an expert in GLP-1 care. He’s also the co-host of the Docs Who Lift podcast.⚡️In this episode Spencer and I discuss emerging research around weight loss injections tirzepatide and semaglutide, known as Ozempic, Wegovy and Mounjaro - and discuss the proper use of these drugs.🎧 Stay tuned to find out:➡︎ Why old restrictions on weight loss drugs are no longer being enforced➡ How a combo of GLP-1 and GIP may be even more revolutionary for weight loss➡︎ Why most people have to take these drugs for life➡︎ Why people get so angry when people lose weight on GLP-1s➡︎  How GLP-1 drugs are going to make weight-loss surgery extinct📕 Chapters(0:41) The non-weight loss benefits from GLP-1 use(4:55) Getting the dosage right(7:24) Drugs of the future(11:09) How to get started on a weight-loss injection(16:38) Why restrictions on weight loss drugs are being lifted(19:46) Why people get mad about GLP-1 use(23:57) Do you have to take these drugs for life?(27:55) Do fat cells have memory?(29:25) What if you want to stop GLP-1 use?(31:48) The mental health drawbacks of weight loss drugs(35:44) Unique insights from Spencer’s time with patients(38:47) Is excessive muscle loss really a big problem?(42:46) Should everyone be taking GLP-1s?(45:14) Will weight loss surgeries go extinct?(49:11) GLP supplements are a scam📱 Connect with me:TikTok: https://www.instagram.com/drkaranrajanYouTube: https://www.youtube.com/@DrKaran Instagram: https://www.tiktok.com/@dr.karanr📱 Connect with Spencer:Instagram: https://www.instagram.com/drnadolsky/ X: https://x.com/DrNadolsky  🔥 Get my free weekly newsletter filled with easy to action health tips, interesting facts and science to fill your curiosity: https://drkaran.beehiiv.com/subscribe🔥 For more useful science for your everyday life, grab my best selling book “This Book May Save Your Life”: https://geni.us/DrKaranBook 🎙️ An OG Podcasts production.

There are no comments yet.

Please log in to write the first comment.